Literature DB >> 23740924

Oral inoculation of chickens with a candidate fowl adenovirus 9 vector.

Li Deng1, Shayan Sharif, Eva Nagy.   

Abstract

Fowl adenoviruses (FAdVs) are a potential alternative to human adenovirus-based vaccine vectors. Our previous studies demonstrated that a 2.4-kb region at the left end of the FAdV-9 genome is nonessential for virus replication and is suitable for the insertion or replacement of transgenes. Our in vivo study showed that the virus FAdV-9Δ4, lacking six open reading frames (ORFs) at the left end of its genome, replicates less efficiently than wild-type FAdV-9 (wtFAdV-9) in chickens that were infected intramuscularly. However, the fecal-oral route is the natural route of FAdV infection, and the oral administration of a vaccine confers some advantages compared to administration through other routes, especially when developing an adenovirus as a vaccine vector. Therefore, we sought to investigate the effects of FAdV-9 in orally inoculated chickens. In the present study, we orally inoculated specific-pathogen-free (SPF) chickens with FAdV-9 and FAdV-9Δ4 and assessed virus shedding, antibody response, and viral genome copy number and cytokine gene expression in tissues. Our data showed that FAdV-9Δ4 replicated less efficiently than did wtFAdV-9, as evidenced by reduced virus shedding in feces, lower viral genome copy number in tissues, and lower antibody response, which are consistent with the results of the intramuscular route of immunization. Furthermore, we found that both wtFAdV-9 and FAdV-9Δ4 upregulated the mRNA expression of alpha interferon (IFN-α), IFN-γ, and interleukin-12 (IL-12). In addition, there was a trend toward downregulation of IL-10 gene expression caused by both viruses. These findings indicate that one or more of the six deleted ORFs contribute to modulating the host response against virus infection as well as virus replication in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740924      PMCID: PMC3754522          DOI: 10.1128/CVI.00187-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  37 in total

1.  Antibody response and virus shedding of chickens inoculated with left end deleted fowl adenovirus 9-based recombinant viruses.

Authors:  Juan Carlos Corredor; Eva Nagy
Journal:  Avian Dis       Date:  2011-09       Impact factor: 1.577

Review 2.  Current issues and future directions of oncolytic adenoviruses.

Authors:  Masato Yamamoto; David T Curiel
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

3.  Coding potential and transcript analysis of fowl adenovirus 4: insight into upstream ORFs as common sequence features in adenoviral transcripts.

Authors:  Bryan D Griffin; Éva Nagy
Journal:  J Gen Virol       Date:  2011-03-23       Impact factor: 3.891

4.  Pathogenicity and complete genome sequence of a fowl adenovirus serotype 8 isolate.

Authors:  Helena Grgić; Dan-Hui Yang; Eva Nagy
Journal:  Virus Res       Date:  2011-01-14       Impact factor: 3.303

5.  Pathotypic and molecular characterization of a fowl adenovirus associated with inclusion body hepatitis in Saskatchewan chickens.

Authors:  Arshud Dar; Susantha Gomis; Ian Shirley; George Mutwiri; Robert Brownlie; Andrew Potter; Volker Gerdts; Suresh K Tikoo
Journal:  Avian Dis       Date:  2012-03       Impact factor: 1.577

6.  The non-essential left end region of the fowl adenovirus 9 genome is suitable for foreign gene insertion/replacement.

Authors:  Juan Carlos Corredor; Eva Nagy
Journal:  Virus Res       Date:  2010-02-02       Impact factor: 3.303

7.  Detection and quantitation of fowl adenovirus genome by a real-time PCR assay.

Authors:  Nadya Romanova; Juan Carlos Corredor; Eva Nagy
Journal:  J Virol Methods       Date:  2009-03-09       Impact factor: 2.014

8.  A region at the left end of the fowl adenovirus 9 genome that is non-essential in vitro has consequences in vivo.

Authors:  Juan Carlos Corredor; Eva Nagy
Journal:  J Gen Virol       Date:  2009-09-16       Impact factor: 3.891

Review 9.  Strategies to overcome host immunity to adenovirus vectors in vaccine development.

Authors:  Erin E Thacker; Laura Timares; Qiana L Matthews
Journal:  Expert Rev Vaccines       Date:  2009-06       Impact factor: 5.217

10.  Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.

Authors:  A Sharma; M Tandon; Y S Ahi; D S Bangari; R Vemulapalli; S K Mittal
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

View more
  6 in total

1.  Pathogenicity and cytokine gene expression pattern of a serotype 4 fowl adenovirus isolate.

Authors:  Helena Grgić; Zvonimir Poljak; Shayan Sharif; Éva Nagy
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

2.  An Inactivated Novel Genotype Fowl Adenovirus 4 Protects Chickens against the Hydropericardium Syndrome That Recently Emerged in China.

Authors:  Qing Pan; Yanchao Yang; Yulong Gao; Xiaole Qi; Changjun Liu; Yanping Zhang; Hongyu Cui; Xiaomei Wang
Journal:  Viruses       Date:  2017-08-08       Impact factor: 5.048

3.  Fowl Adenovirus 4 (FAdV-4)-Based Infectious Clone for Vaccine Vector Development and Viral Gene Function Studies.

Authors:  Yanlong Pei; Juan C Corredor; Bryan D Griffin; Peter J Krell; Éva Nagy
Journal:  Viruses       Date:  2018-02-24       Impact factor: 5.048

4.  Downregulation of Cell Surface Major Histocompatibility Complex Class I Expression Is Mediated by the Left-End Transcription Unit of Fowl Adenovirus 9.

Authors:  Bryan D Griffin; Juan Carlos Corredor; Yanlong Pei; Éva Nagy
Journal:  Viruses       Date:  2021-11-03       Impact factor: 5.048

5.  A Novel Recombinant FAdV-4 Virus with Fiber of FAdV-8b Provides Efficient Protection against Both FAdV-4 and FAdV-8b.

Authors:  Hao Lu; Quan Xie; Wei Zhang; Jianjun Zhang; Weikang Wang; Mingjun Lian; Zhehong Zhao; Dan Ren; Songhua Xie; Yun Lin; Tuofan Li; Yaru Mu; Zhimin Wan; Hongxia Shao; Aijian Qin; Jianqiang Ye
Journal:  Viruses       Date:  2022-02-11       Impact factor: 5.048

Review 6.  Bovine adenovirus-3 as a vaccine delivery vehicle.

Authors:  Lisanework E Ayalew; Pankaj Kumar; Amit Gaba; Niraj Makadiya; Suresh K Tikoo
Journal:  Vaccine       Date:  2014-12-09       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.